Regulation of basal gastric acid secretion by the glycogen synthase kinase GSK3
✍ Scribed by Anand Rotte; Venkanna Pasham; Melanie Eichenmüller; Wenting Yang; Syed M. Qadri; Madhuri Bhandaru; Florian Lang
- Publisher
- Springer Japan
- Year
- 2010
- Tongue
- English
- Weight
- 509 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
synthase kinase-3 (GSK-3) Radiosynthesis Positron emission tomography (PET) Cancer Alzheimer's disease a b s t r a c t SB-216763 is a novel, potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor with an IC 50 value of 34 nM. , a new potential PET agent for imaging of GSK-3, was first de
## Abstract Insulin‐like growth factor II (IGF‐II) plays a key role in mitogenesis during development and tumorigenesis and is believed to exert its mitogenic functions mainly through the IGF‐I receptor. Recently, we identified the insulin receptor isoform A (IR^A^) as an additional high affinity r
## Abstract The upstream binding factor 1 (UBF1), one of the proteins that regulate the activity of RNA polymerase I, is downregulated in 32D myeloid cells induced to differentiate into granulocytes, either by the type 1 insulin‐like growth factor (IGF‐1) or the granulocytic colony stimulating fact
## Abstract Excitotoxicity and cell death induced by glutamate are involved in many neurodegenerative disorders. We have previously demonstrated that excitotoxicity induced by millimolar concentrations of glutamate in hippocampal slices involves apoptotic features and glutamate‐induced glutamate re
## Abstract We have evaluated the effect of peripheral insulin deficiency on brain insulin pathway activity in a mouse model of type 1 diabetes, the parallels with Alzheimer's disease (AD), and the effect of treatment with insulin. Nine weeks of insulin‐deficient diabetes significantly impaired the